Market Tracker

12/19 11:01pm ET

Emergent BioSolutions Inc (NYSE:EBS)

27.05
Data as of Dec 19
 +0.07 / +0.26%
Today’s Change
19.31
Today|||52-Week Range
28.48
+17.66%
Year-to-Date

Today’s Trading

Previous close26.98
Today’s open26.98
Day’s range26.40 - 27.85
Volume706,975
Average volume (3 months)210,463
Market cap$1.0B
Dividend yield--
Data as of 4:05pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+30.77%
Earnings growth (this year)+14.12%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)+10.95%
P/E ratio58.8
Price/Sales2.66
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+0.19+0.36%
SAGESAGE Therapeutics In...-0.13-0.32%
FWPForward Pharma A/S+0.76+3.68%
MGNXMacroGenics Inc+0.70+2.07%
Data as of 4:00pm ET, 12/19/2014

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)$0.64
Annual revenue (last year)$312.7M
Annual profit (last year)$31.1M
Net profit margin9.96%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts